Immunological characterization of C3H mice congenic for Fas(lprcg), C3H/HeJ-Fas(lcrpg)/Fas(lcrpg)

Laboratory Animals

Volumn 34, Issue 1, 2000, Pages 46-55

  Yasuda, Takuwa ^a   Zhang, Yan ^a   Nagase, Hisashi ^b   Kaneko, Tetsuya ^a   Sayama, Kazutoshi ^c   Hashimoto, Hajime ^d   Matsuzawa, Akio ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SHIZUOKA UNIVERSITY   (Japan)

^d MEIJI GAKUIN UNIVERSITY   (Japan)

Author keywords

Autoimmunity; C3H background; Fas mutations; Fas(lprcg); Lymphadenopathy

Indexed keywords

AUTOANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; DOUBLE STRANDED DNA; FAS LIGAND; IMMUNOGLOBULIN ANTIBODY;

APOPTOSIS; ARTICLE; CELL INFILTRATION; CELL SURFACE; FEMALE; GENE MUTATION; IMMUNOGLOBULIN BLOOD LEVEL; LIVER; LUNG; LYMPHADENOPATHY; LYMPHOCYTE PROLIFERATION; LYMPHOID CELL; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; SPLENOMEGALY; T LYMPHOCYTE;

EID: 0033965874     PISSN: 00236772     EISSN: None     Source Type: Journal    
DOI: 10.1258/002367700780578019     Document Type: Article

References (25)

1. Alderson MR, Armitage RL, Marakovsky E, et al. (1993) Fas transduces activation signals in normal human T lymphocytes. Journal of Experimental Medicine 178, 2231-5
2. Allen RD, Marshall JD, Roths JB, Sidman CL (1990) Differences defined by bone marrow transplantation suggest that lpr and gld are mutations of genes encoding an interacting pair of molecules. Journal of Experimental Medicine 172, 1367-75
3. Biacone L, de Maritino A, Orlandi V, Conaldi PG, Toniolo A, Camussi G (1997) Development of inflammatory angiogenesis by local stimulation of Fas in vivo. Journal of Experimental Medicine 186, 147-52
4. Chu JL, Romos P, Rosendoff A, et al. (1995) Massive upregulation of the Fas ligand in lpr and gld mice: implications for Fas regulation and graft-versus-host disease-like wasting syndrome, Journal of Experimental Medicine 181, 393-8
5. Cohen PL, Eisenberg RA (1991) Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annual Review of Immunology 9, 243-69
6. Dao T, Huleatt JW, Hingorani R, Crispe N (1997) Specific resistance of T cells to CD95-induced apoptosis during S phase of the cell cycle. Journal of Immunology 159, 4261-7
7. Giese T, Davidson WF (1994) Chronic treatment of C3H-lpr/lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double negative T cells but not autoantibody production. Journal of Immunology 152, 2000-10
8. Izui S, Kelley WE, Masuda K, Yoshida H, Roths JB, Murphy ED (1984) Induction of various autoantibodies by mutant gene lpr in several strains of mice. Journal of Immunology 133, 227-33
9. Kelley VE, Roths JB (1985) Interaction of mutant lpr gene with background strain influences renal disease. Clinical Immunology and Immunopathology 37, 220-29
10. cg gene on the MRL background. Immunology 76, 498-504
11. cg: a novel mutant gene. International Review of Immunology 11, 193-210
12. Kobayashi S, Hirano T, Kashinuma M, Uede T (1993) Transcriptional repression and differential splicing of Fas mRNA by early transposon (ETn) insertion in autoimmune lpr mice. Biochemical Biophysical Research Communication 191, 617-24
13. cg, that complements the gld gene in induction of lymphadenopathy in the mouse. Journal of Experimental Medicine 171, 519-31
14. Murphy ED, Roths JB (1978) Autoimmunity and lymphoproliferation: induction by mutant gene lpr and acceleration by a male-associated factor in strain BXSB mice. In: Genetic Control of Autoimmune Disease (Rose NR, Bigazzi PE, Warner NL, eds). Amsterdam: Elsevier, pp 207-20
15. Nagata S, Goldstein P (1995) The Fas death factor. Science 267, 1449-56
16. Nagata S, Suda T (1995) Fas and Fas ligand: lpr and gld mutations. Immunology Today 16, 39-43
17. Seino K, Kayagaki N, Okumura K, Yagita H (1997) Antitumor effect of locally produced CD95 ligand Nature Medicine 3, 165-70
18. Seino K, Iwabuchi K, Kayagaki N, et al. (1998) Chemotactic activity of soluble Fas ligand against phagocytes. Journal of Immunology 161, 4484-8
19. Shimizu M, Yoshimoto T, Nagata S, Matsuzawa A (1996) A trial to kill tumor cells through Fas (CD95)-mediated apoptosis in vivo. Biochemical Biophysical Research Communication 228, 375-9
20. Tanaka S, Matsuzawa A, Kato H, Esaki K, Sudo K, Yamanouchi K (1987) Inbred strains of mice maintained at the Institute of Medical Science, University of Tokyo. Japanese Journal of Experimental Medicine 57, 241-5
21. Theofilopoulos AN, Dixon F (1985) Murine models of systemic lupus erythematosus. Advances in Immunology 37, 269-390
22. Wang Y, Nose M, Kamoto T, Nishimura M, Hiai H (1997) Host modifier genes affect mouse autoimmunity induced by the lpr gene. American Journal of Pathology 151, 1791-8
23. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jevkius NA, Nagata S (1992) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis Nature 356, 314-17
24. Watson ML, Ras JK, Gilkson GS, et al. (1992) Genetic analysis of MRL-lpr mice: relationship of Fas apoptosis gene to disease manifestations and renal disease-modifying loci. Journal of Experimental Medicine 176, 1645-65
25. Wofsy D, Hardy RR, Seaman WE (1984) The proliferating cells in autoimmune MRL/lpr mice lack L3T4, an antigen on 'helper' T cells that is involved in the response to class II major histocompatibility antigens. Journal of Immunology 132, 2686-9